FR2297635B1 - - Google Patents

Info

Publication number
FR2297635B1
FR2297635B1 FR7600974A FR7600974A FR2297635B1 FR 2297635 B1 FR2297635 B1 FR 2297635B1 FR 7600974 A FR7600974 A FR 7600974A FR 7600974 A FR7600974 A FR 7600974A FR 2297635 B1 FR2297635 B1 FR 2297635B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7600974A
Other languages
French (fr)
Other versions
FR2297635A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/541,512 external-priority patent/US4029763A/en
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of FR2297635A1 publication Critical patent/FR2297635A1/fr
Application granted granted Critical
Publication of FR2297635B1 publication Critical patent/FR2297635B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7600974A 1975-01-16 1976-01-15 Vaccin antigrippal contenant un antigene neuraminidase purifie et application Granted FR2297635A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/541,512 US4029763A (en) 1974-08-05 1975-01-16 Influenza vaccine containing purified neuraminidase antigen and method of using the same

Publications (2)

Publication Number Publication Date
FR2297635A1 FR2297635A1 (fr) 1976-08-13
FR2297635B1 true FR2297635B1 (US06252093-20010626-C00008.png) 1980-06-27

Family

ID=24159889

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7600974A Granted FR2297635A1 (fr) 1975-01-16 1976-01-15 Vaccin antigrippal contenant un antigene neuraminidase purifie et application

Country Status (7)

Country Link
AU (1) AU507149B2 (US06252093-20010626-C00008.png)
BE (1) BE837603A (US06252093-20010626-C00008.png)
CA (1) CA1073355A (US06252093-20010626-C00008.png)
FR (1) FR2297635A1 (US06252093-20010626-C00008.png)
GB (1) GB1536475A (US06252093-20010626-C00008.png)
NL (1) NL7600443A (US06252093-20010626-C00008.png)
PH (1) PH13837A (US06252093-20010626-C00008.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344935A (en) 1980-06-05 1982-08-17 Synthelabo Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344935A (en) 1980-06-05 1982-08-17 Synthelabo Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines

Also Published As

Publication number Publication date
PH13837A (en) 1980-10-16
AU1016376A (en) 1977-07-14
NL7600443A (nl) 1976-07-20
AU507149B2 (en) 1980-02-07
BE837603A (fr) 1976-05-03
CA1073355A (en) 1980-03-11
FR2297635A1 (fr) 1976-08-13
GB1536475A (en) 1978-12-20

Similar Documents

Publication Publication Date Title
IN146132B (US06252093-20010626-C00008.png)
JPS5646233Y2 (US06252093-20010626-C00008.png)
FR2297635B1 (US06252093-20010626-C00008.png)
BG21320A1 (US06252093-20010626-C00008.png)
BG21746A1 (US06252093-20010626-C00008.png)
BG22049A1 (US06252093-20010626-C00008.png)
BG22117A1 (US06252093-20010626-C00008.png)
BG22247A1 (US06252093-20010626-C00008.png)
BG22714A1 (US06252093-20010626-C00008.png)
BG22894A1 (US06252093-20010626-C00008.png)
BG23448A1 (US06252093-20010626-C00008.png)
BG26465A1 (US06252093-20010626-C00008.png)
CH1422975A4 (US06252093-20010626-C00008.png)
CH178775A4 (US06252093-20010626-C00008.png)
CH220276A4 (US06252093-20010626-C00008.png)
CH580780A5 (US06252093-20010626-C00008.png)
CH582759A5 (US06252093-20010626-C00008.png)
CH586582A5 (US06252093-20010626-C00008.png)
CH586681A5 (US06252093-20010626-C00008.png)
CH586820A5 (US06252093-20010626-C00008.png)
CH588789A5 (US06252093-20010626-C00008.png)
CH589223A5 (US06252093-20010626-C00008.png)
CH590507B5 (US06252093-20010626-C00008.png)
CH591627A5 (US06252093-20010626-C00008.png)
CH592425A5 (US06252093-20010626-C00008.png)